Literature DB >> 5124412

Multiple drug therapy for disseminated malignant tumours.

L A Price, J H Goldie.   

Abstract

Forty patients with various disseminated malignant tumours were treated with up to six antitumour drugs given for periods not exceeding 24 hours. Complete or partial objective tumour regression was achieved in 20 patients. No regression occurred in the remaining 20. Treatment given in this way seemed to be at least as effective as other multiple drug regimens and had the following advantages: (1) toxicity was reduced to a minimum and no access was needed to sterile rooms or platelet transfusions since severe bone marrow depression did not occur, and (2) the patients spent only a very short time in hospital.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5124412      PMCID: PMC1799395          DOI: 10.1136/bmj.4.5783.336

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.

Authors:  J J Costanzi; C A Coltman
Journal:  Cancer       Date:  1969-03       Impact factor: 6.860

2.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

Authors:  W R Bruce; B E Meeker; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1966-08       Impact factor: 13.506

  2 in total
  12 in total

1.  Letter: Kinetic classifications of Antitumour Drugs.

Authors:  B T Hill; L A Price
Journal:  Br Med J       Date:  1975-08-09

2.  20-hour combination chemotherapy in advanced breast cancer.

Authors:  J H Goldie; L A Price
Journal:  Br Med J       Date:  1977-10-22

3.  Letter: Chemotherapy of disseminated malignant tumours.

Authors:  D A Cook
Journal:  Br Med J       Date:  1974-01-12

4.  Combination chemotherapy.

Authors:  E Frei
Journal:  Proc R Soc Med       Date:  1974-06

5.  Leiomyosarcoma of the stomach with 45-year survival.

Authors:  G D Hart; M L Soots; S Yoshida
Journal:  Can Med Assoc J       Date:  1972-12-23       Impact factor: 8.262

6.  Prostatic cancer.

Authors:  L A Price; B T Hill
Journal:  Br Med J       Date:  1977-01-08

7.  Choosing treatment for metastatic breast cancer.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

Review 8.  Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.

Authors:  F M Torti; W G Harker
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Adjuvant chemotherapy for early breast cancer.

Authors:  L A Price; B T Hill
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

10.  Combination chemotherapy for testicular tumours.

Authors:  T J McElwain; M J Peckham
Journal:  Proc R Soc Med       Date:  1974-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.